NYSE:NBY

Novabay Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy NBY

*Your capital is at risk

$1.47

+0 (+0%)

At Close: Jun 03, 2026

NovaBay Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 344.64M and sold 441.33K NBY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	344.64M shares
● Sell	441.33K shares
99% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence May 21, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 100. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 26, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	6 302 Value: $4K
Feb 25, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	25 033 Value: $15.5K
Feb 25, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	25 033 Value: $15.5K
Feb 24, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	450 Value: $279
Feb 24, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	450 Value: $279
Feb 20, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	1 836 Value: $1K
Feb 20, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	1 836 Value: $1K
Feb 19, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	49 664 Value: $33.3K
Feb 19, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	49 664 Value: $33.3K
Feb 18, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	3 222 Value: $2K
Feb 18, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	3 222 Value: $2K
Feb 04, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	26 718 Value: $17.0K
Feb 04, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	26 718 Value: $17.0K
Feb 03, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	2 597 Value: $2K
Feb 03, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	2 597 Value: $2K
Jan 31, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	70 685 Value: $45.8K
Jan 31, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	70 685 Value: $45.8K
Jan 27, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	31 703 Value: $21.9K
Jan 27, 2025 Buy	Common Stock, par value $0.01 per share P-Purchase	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	31 703 Value: $21.9K
Jan 10, 2025 Buy	COMMON STOCK, PAR VALUE $0.01	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	0 Value: $0
Jan 10, 2025 Buy	COMMON STOCK, PAR VALUE $0.01	Poplar Point Capital Partners Lp 10 Percent Owner	10% Owner	0 Value: $0
May 28, 2024 Buy	Restricted Stock Units A-Award	Zheng Yenyou Director	Director	30 000 Value: $0
May 28, 2024 Buy	Restricted Stock Units A-Award	Wu Mijia Director	Director	30 000 Value: $0
May 28, 2024 Buy	Restricted Stock Units A-Award	Sit Swan Director	Director	30 000 Value: $0
May 28, 2024 Buy	Restricted Stock Units A-Award	Freiman Paul E. Director	Director	30 000 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NOVABAY PHARMACEUTICALS, INC

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising ...

Read Full Profile Here